SenesTech Inc (NASDAQ:SNES)’s share price traded down 8.4% on Friday . The company traded as low as $0.87 and last traded at $0.87, 15,492 shares traded hands during trading. A decline of 91% from the average session volume of 177,637 shares. The stock had previously closed at $0.95.

Separately, ValuEngine raised shares of SenesTech from a “hold” rating to a “buy” rating in a research report on Friday, June 28th.

The stock’s 50-day moving average price is $1.28 and its two-hundred day moving average price is $1.37. The stock has a market capitalization of $26.04 million, a P/E ratio of -1.41 and a beta of 1.93. The company has a current ratio of 3.73, a quick ratio of 2.60 and a debt-to-equity ratio of 0.07.

SenesTech (NASDAQ:SNES) last released its earnings results on Tuesday, August 13th. The company reported ($0.09) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.10) by $0.01. SenesTech had a negative net margin of 3,432.63% and a negative return on equity of 169.12%. The firm had revenue of $0.02 million during the quarter.

In other SenesTech news, insider Cheryl Ann Dyer sold 40,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1.19, for a total value of $47,600.00. Following the sale, the insider now directly owns 391,165 shares in the company, valued at approximately $465,486.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kenneth S. Siegel bought 696,296 shares of the stock in a transaction on Tuesday, July 16th. The stock was purchased at an average price of $1.35 per share, for a total transaction of $939,999.60. Following the completion of the purchase, the chief executive officer now directly owns 702,558 shares in the company, valued at $948,453.30. The disclosure for this purchase can be found here. 10.91% of the stock is currently owned by company insiders.

Institutional investors have recently bought and sold shares of the company. First Interstate Bank purchased a new stake in shares of SenesTech during the 2nd quarter valued at $31,000. MRA Associates USA LLC purchased a new stake in shares of SenesTech during the 2nd quarter valued at $46,000. Bank of New York Mellon Corp purchased a new stake in shares of SenesTech during the 2nd quarter valued at $62,000. Meitav Dash Investments Ltd. purchased a new stake in shares of SenesTech during the 1st quarter valued at $81,000. Finally, BlackRock Inc. purchased a new stake in shares of SenesTech during the 2nd quarter valued at $115,000. Hedge funds and other institutional investors own 7.13% of the company’s stock.

About SenesTech (NASDAQ:SNES)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. The company focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

Featured Story: Gap Up Stocks

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.